Aurobindo Pharma has informed about a Press Release dated December 22, 2015 titled ‘Aurobindo Pharma receives USFDA Approval for Olopatadine Hydrochloride Ophthalmic Solution’.
The above information is a part of company’s filings submitted to BSE.